StudyFinder
PREvention of CardIovascular and DiabEtic kidNey disease in Type 2 Diabetes (PRECIDENTD)
Status: Recruiting
People with type 2 diabetes have a higher risk for heart disease than people without diabetes. We are doing this research to learn more about which diabetes medications are the best for lowering the risk of heart and kidney disease for people with type 2 diabetes. People who are in the study will be randomly (by chance) assigned to take one of two types of diabetes medications that have been approved by the FDA. Your usual care provider will continue to manage your diabetes care.
Sex: Male or Female
Age Group: 18 years and over
Inclusion Criteria:
• 40 to 80 years old with -diagnosis of Type 2 diabetes, HbA1c ≥6% measured in the past 12 months,
• AND one of the following:
• diagnosis of coronary heart disease, cerebrovascular disease, or symptomatic peripheral artery disease
• OR: -60-80 years old and at least 1 additional high-risk feature:
• active smoking, HbA1c ≥ 8% measured within past 12 months or chronic kidney disease
• willing to be randomly (by chance) assigned to a class of medication and fill the prescription with personal pharmacy insurance plan
• see link to clinicaltrials.gov for complete inclusion criteria
Exclusion Criteria:
• any other type of diabetes
• history of diabetic ketoacidosis
• active diabetic foot ulcer
• history of pancreatitis
• active treatment for cancer
• history of solid organ or bone marrow transplant
• see link to clinicaltrials.gov for complete exclusion criteria
Conditions:
Diabetes & Endocrine
Keywords:
ASCVD, Atherosclerotic Cardiovascular Disease, Diabetes, Type2Diabetes
Study Contact: PRECIDENTD STUDY - precidentd@umn.edu
Principal Investigator: Elizabeth Rogers
Phase: PHASE4
IRB Number: STUDY00024423
See this study on ClinicalTrials.gov